165 related articles for article (PubMed ID: 12014596)
21. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
22. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
Bukstein OG; Kolko DJ
J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
[TBL] [Abstract][Full Text] [Related]
23. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
24. Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects.
Rapport MD; Moffitt C
Clin Psychol Rev; 2002 Nov; 22(8):1107-31. PubMed ID: 12436807
[TBL] [Abstract][Full Text] [Related]
25. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
26. Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate?
Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
Seizure; 2015 Feb; 25():80-3. PubMed ID: 25645642
[TBL] [Abstract][Full Text] [Related]
27. Daily methylphenidate use slows the growth of children: a community based study.
Lisska MC; Rivkees SA
J Pediatr Endocrinol Metab; 2003 Jun; 16(5):711-8. PubMed ID: 12880120
[TBL] [Abstract][Full Text] [Related]
28. Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.
Greenhill L; Beyer DH; Finkleson J; Shaffer D; Biederman J; Conners CK; Gillberg C; Huss M; Jensen P; Kennedy JL; Klein R; Rapoport J; Sagvolden T; Spencer T; Swanson JM; Volkow N
J Atten Disord; 2002; 6 Suppl 1():S89-100. PubMed ID: 12685523
[TBL] [Abstract][Full Text] [Related]
29. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
[TBL] [Abstract][Full Text] [Related]
30. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
31. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy.
Palumbo D; Spencer T; Lynch J; Co-Chien H; Faraone SV
J Child Adolesc Psychopharmacol; 2004; 14(2):185-94. PubMed ID: 15319016
[TBL] [Abstract][Full Text] [Related]
32. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
[TBL] [Abstract][Full Text] [Related]
33. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
Golubchik P; Sever J; Zalsman G; Weizman A
Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
35. Effect of stimulants on height and weight: a review of the literature.
Faraone SV; Biederman J; Morley CP; Spencer TJ
J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
[TBL] [Abstract][Full Text] [Related]
36. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
37. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
38. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
Durukan I; Türkbay T; Cöngöloğlu A
Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
[TBL] [Abstract][Full Text] [Related]
39. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
[TBL] [Abstract][Full Text] [Related]
40. [Attention deficit disorder: multidisciplinary observational study over 1 year].
Chambry J; Billard C; Guinard M; Lacaze E; Idiart ME; Delteil-Pinton F; Cohen de Lara A
Encephale; 2011 Jun; 37(3):180-90. PubMed ID: 21703433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]